Business news – Page 86
-
Business
Norway abandons full-scale CCS project
Technology development centre will receive extra funding
-
OpinionWhat's the use?
Not every reaction can be run in a bucket, says Derek Lowe, but there are limits to what should be classed as ‘useful’
-
BusinessNew respiratory drugs neck and neck
Combination inhalers from GSK and Novartis approved in EU and Japan
-
Business
Nanobody inflammation drug attracts Abbvie
$840m licensing deal shows support for antibody fragments
-
BusinessService with a smile
Company profile: Charnwood Molecular is more than a run-of-the-mill contract synthesis provider
-
Business
GSK criticised for trial data secrecy
Italian research institute abandons collaboration over data access
-
Business
UK objects to pesticide ban in gardens
Government disagrees with EU neonicotinoid moratorium, but will implement it
-
Business
First biosimilar antibody drugs approved in Europe
European commission gives final approval to generic infliximab copies
-
Business
GSK divests Lucozade and Ribena brands
£1.35 billion deal allows GSK to focus on pharma business
-
Business
Otsuka to buy Astex for $886 million
Japanese firm intends to leave Astex’s fragment-based R&D efforts intact
-
Business
Amgen snaps up Onyx in huge biotech deal
$10.4 billion acquisition will expand firm’s oncology portfolio
-
Business
Lundbeck appeals European antitrust fine
Danish pharmaceutical claims €93.8 million pay-for-delay penalty was the result of ‘serious legal and factual errors’
-
Business
Endo Health to buy Boca Pharmacal for $225m
Endo agrees to buy generics firm Boca as two major patents expire
-
Business
Nice rules against Afinitor
Novartis’ drug will not routinely be available on the UK health service
-
Business
Syngenta takes legal action over pesticide ban
Company claims that the European commission’s two-year moratorium on neonicotinoids to protect bees was wrong
-
Business
Couple charged in GSK corruption investigation
Two private investigators have been charged with breaching the privacy rights of Chinese citizens
-
Business
J&J buys Aragon’s prostate cancer arm
Hormone cancer specialist spins out other programmes before sale
-
BusinessTwo way traffic for Chinese drug licensing
Western companies are seeing more value in Chinese innovation
-
Business
Boehringer to close manufacturing plants and cut jobs
Two US plants and a total of 640 jobs to go by the end of next year